156 related articles for article (PubMed ID: 7921283)
1. [Immunohematologic surveillance of patients treated with ABO incompatible bone marrow allografts].
Mizon P; Jouet JP; Vanhaesbroucke C; Villard F; Wibaut B; Goudemand J
Transfus Clin Biol; 1994; 1(4):271-7. PubMed ID: 7921283
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
Rowley SD; Liang PS; Ulz L
Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
[TBL] [Abstract][Full Text] [Related]
3. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
[TBL] [Abstract][Full Text] [Related]
4. Isoagglutinins following ABO-incompatible bone marrow transplantation.
Wernet D; Mayer G
Vox Sang; 1992; 62(3):176-9. PubMed ID: 1609520
[TBL] [Abstract][Full Text] [Related]
5. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
[TBL] [Abstract][Full Text] [Related]
6. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
[TBL] [Abstract][Full Text] [Related]
7. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
[TBL] [Abstract][Full Text] [Related]
8. ABO-incompatible bone marrow transplantation.
Wiesneth M; Hertenstein B; Bunjes D; Schmeiser T; Maccari B; Northoff H; Laasch H; Heit W; Arnold R; Heimpel H
Beitr Infusionsther; 1992; 30():354-8. PubMed ID: 1284733
[TBL] [Abstract][Full Text] [Related]
9. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
Lasky LC; Warkentin PI; Kersey JH; Ramsay NK; McGlave PB; McCullough J
Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549
[TBL] [Abstract][Full Text] [Related]
10. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.
Ockelford PA; Hill RS; Nelson L; Blacklock HA; Woodfield DG; Matthews JR
Transfusion; 1982; 22(1):62-5. PubMed ID: 7039010
[TBL] [Abstract][Full Text] [Related]
11. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte depletion of ABO-incompatible bone marrow.
Sniecinski I; Henry S; Ritchey B; Branch DR; Blume KG
J Clin Apher; 1985; 2(3):231-4. PubMed ID: 3897206
[TBL] [Abstract][Full Text] [Related]
13. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
[TBL] [Abstract][Full Text] [Related]
14. Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation.
Lee JH; Lee JH; Choi SJ; Kim S; Seol M; Kwon SW; Park CJ; Chi HS; Lee JS; Kim WK; Lee KH
Br J Haematol; 2003 Feb; 120(4):702-10. PubMed ID: 12588361
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplant.
López J; Steegmann JL; Pérez G; Otero MJ; Berberana M; Cámara R; Lamana M; Fernández Villalta MJ; Fernández-Rañada JM
Am J Hematol; 1994 Mar; 45(3):237-9. PubMed ID: 8296795
[TBL] [Abstract][Full Text] [Related]
16. Is the ABO incompatibility a risk factor in bone marrow transplantation?
Rozman P; Kosir A; Bohinjec M
Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
[TBL] [Abstract][Full Text] [Related]
17. A preliminary report on ABO incompatible bone marrow transplant.
Tan P; Ong YW; Tien SL; Loh TF; Lim ST
Ann Acad Med Singap; 1991 Jul; 20(4):421-8. PubMed ID: 1799251
[TBL] [Abstract][Full Text] [Related]
18. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
[TBL] [Abstract][Full Text] [Related]
19. [Effect of ABO-incompatible allogeneic stem cell transplantation on erythroid lineage hematopoiesis].
Cai XJ; Hong JY; Chen Y; Yu K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):801-4. PubMed ID: 21729575
[TBL] [Abstract][Full Text] [Related]
20. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility.
Nussbaumer W; Schwaighofer H; Gratwohl A; Kilga S; Schönitzer D; Nachbaur D; Niederwieser D
Transfusion; 1995 Jul; 35(7):592-5. PubMed ID: 7631393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
